Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

L-ornidazole prepn

A preparation technology of L-ornidazole, which is applied in the field of preparation of nitroimidazole antibiotics L-ornidazole, can solve the problems of high toxicity and poor activity of ornidazole racemate, and achieve long half-life, no special toxicity, The effect of good application prospects

Inactive Publication Date: 2006-03-01
YANGTZE RIVER PHARM GRP CO LTD
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, the ornidazole racemate is sold and clinically used in the market, and the ornidazole racemate has poor activity and relatively high toxicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • L-ornidazole prepn
  • L-ornidazole prepn

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Make 1000 L-ornidazole tablets with the raw materials in the following weight ratio, and the tablet weight is 435mg

[0019] Levonidazole 250g

[0020] Pregelatinized starch 50g

[0021] Microcrystalline Cellulose 100g

[0022] 3% HPMC 40% ethanol solution appropriate amount

[0023] Sodium carboxymethyl starch 30g

[0024] Magnesium Stearate 3g

[0025] Preparation Process:

[0026] 1. Raw materials and auxiliary materials of L-ornidazole are pulverized separately and passed through a 100-mesh sieve.

[0027] 2. Take L-ornidazole, pregelatinized starch, and microcrystalline cellulose and mix well, use 3% HPMC 40% ethanol solution to make soft material, granulate, and granulate after drying.

[0028] 3. Add sodium carboxymethyl starch and magnesium stearate, mix well, and press into tablets.

Embodiment 2

[0030] 1. Prepare 6% ethanol solution of Opadry enteric coating solution;

[0031] 2. Take the plain tablet obtained in Example 1 and pour it into a coating pan for coating to obtain L-ornidazole enteric-coated tablet. Coating powder relative to tablet core weight gain: 4.0-5.0%.

Embodiment 3

[0033] Prepare 1000 L-ornidazole tablets with the raw materials in the following weight ratio, and the tablet weight is 230 mg.

[0034] Levonidazole 125g

[0035] 30g pregelatinized starch

[0036] Microcrystalline Cellulose 50g

[0037] 3% HPMC 40% ethanol solution appropriate amount

[0038] Sodium carboxymethyl starch 20g

[0039] Magnesium Stearate 2g

[0040] Preparation Process:

[0041] 1. Separately pulverize the L-ornidazole raw material and auxiliary materials, and pass through a 100-mesh sieve.

[0042] 2. Take L-ornidazole, pregelatinized starch, and microcrystalline cellulose and mix well, use 3% HPMC 40% ethanol solution to make soft material, granulate, and granulate after drying.

[0043] 3. Add sodium carboxymethyl starch and magnesium stearate, mix well, and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sheet weightaaaaaaaaaa
Login to View More

Abstract

The present invention discloses L-ornidazole preparation as one kind of nitroimidazole antibiotics. The L-ornidazole preparation contains L-ornidazole or its salt or their hydrate. L-ornidazole is named chemically as S-(+)-1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole. The L-ornidazole preparation is prepared with L-ornidazole and supplementary material, and may be prepared in tablet, dispersant tablet, coated tablet, enteric tablet, capsule or granule. Compared with similar preparations, the L-ornidazole preparation has high pharmacodynamic activity, lower toxicity and stable quality.

Description

technical field [0001] The invention relates to a preparation of nitroimidazole antibiotic L-ornidazole. Background technique [0002] At present, the ornidazole racemate is sold and clinically used in the market, and the ornidazole racemate has poor activity and relatively high toxicity. Contents of the invention [0003] In order to improve the activity of medicines and reduce toxicity, the invention provides a preparation of single optical isomer levo-ornidazole. [0004] In order to achieve the above object, the present invention adopts the following technical scheme: a levo-ornidazole preparation, which comprises levo-ornidazole or its salt or their hydrates shown in the following structural formula; chemical name is: S-(+)- 1-(3-Chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole; it is oral ordinary tablet, dispersible tablet, Film-coated tablets, enteric-coated tablets, hard capsules and granules. [0005] [0006] The molecular formula is: C 7 h 10 ClN 3 o ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4164A61P31/10A61P33/02
Inventor 蔡伟金波乔阳李浩冬
Owner YANGTZE RIVER PHARM GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products